Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Enoblituzumab (Anti-B7-H3 / CD276) For research use only.
Not for use in humans.

Enoblituzumab (Anti-B7-H3 / CD276)

Synonyms: MGA271

Enoblituzumab (Anti-B7-H3 / CD276) is a humanized IgG1κ monoclonal antibody targeting human B7-H3 protein. It can be used in the treatment of medullary thyroid cancer (MTC). MW :150 KD.

Enoblituzumab (Anti-B7-H3 / CD276)

Purity & Quality Control

Batch: A262601 Purity: 99% Protein concentration: 4.87mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective CD markers Inhibitors

Biological Activity

Description Enoblituzumab (Anti-B7-H3 / CD276) is a humanized IgG1κ monoclonal antibody targeting human B7-H3 protein. It can be used in the treatment of medullary thyroid cancer (MTC). MW :150 KD.

Product Details

CAS No. 1353485-38-7
Molecular Weight 150
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Enoblituzumab (Anti-B7-H3 / CD276) | Enoblituzumab (Anti-B7-H3 / CD276) supplier | purchase Enoblituzumab (Anti-B7-H3 / CD276) | Enoblituzumab (Anti-B7-H3 / CD276) cost | Enoblituzumab (Anti-B7-H3 / CD276) manufacturer | order Enoblituzumab (Anti-B7-H3 / CD276) | Enoblituzumab (Anti-B7-H3 / CD276) distributor